Bill > HB4814

This bill requires health insurers in Michigan to provide coverage for medically necessary treatments related to menopause and perimenopause, including hormone replacement therapy (HRT) that is approved by the U.S. Food and Drug Administration (FDA). The bill prohibits insurers from requiring prior authorization, step therapy, or fail-first protocols for medications used to treat menopause and perimenopause symptoms. Specifically, the bill defines menopause as the permanent end of menstruation due to loss of ovarian function, and perimenopause as the transitional period near the end of reproductive years or at the onset of menopause. By removing barriers like prior authorization, the bill aims to make it easier for individuals experiencing menopausal symptoms to access appropriate medical treatments without additional administrative hurdles from their health insurance providers.

Business and Industry

https://legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4814